Our previous work showed that NK cells briefly stimulated with IL-12, IL-15, and IL-18 become long-lived, memory-like (ML) NK cells with the ability to respond robustly upon restimulation with cytokines and activating receptors, including CD16 engagement with tumor-targeting mAbs (24, 39–41). Here, IL15 is linked to neoplasm.